Abstract:Percutaneous transluminal coronary angioplasty (PTCA) and stents are presently potential strategies against coronary artery diseases. However, the long-term outcome of these techniques is limited by in- stent restenosis (ISR). With the recent advent of drug-eluting stents (DES), we discover a new promising weapon to overcome the “Achilles’ heel” of interventional cardiology. Recently, more and more clinical data on DES from trials are encouraging us to use it against more challenging coronary lesions such as chronic total occlusions, complex lesions and multivessel lesions. With the research and development of better devices, the treatment of coronary artery disease will improve.

The Status and Prospect of Drug-Eluting Stents(DES) in Percutaneous Coronary Intervention(PCI)